Psych/Administrative & Academic Special Programs
Showing 1-100 of 120 Results
-
John Wesson Ashford Jr
Clinical Professor (Affiliated), Psych/Public Mental Health & Population Sciences
Staff, Psychiatry and Behavioral SciencesBioDr. Ashford is a Clinical Professor of Psychiatry and Behavioral Sciences (affiliated) at Stanford University and has been a staff psychiatrist since 2003 and the Director of the War Related Illness and Injury Study Center (WRIISC) at the VA Palo Alto Health Care System since 2007. Dr. Ashford is a Senior Research Scientist at the Stanford / VA Aging and Alzheimer's Disease Clinical Research Centers. He is a member of the Scientific Advisory Board and Chair of the Memory Screening Advisory Board of the Alzheimer's Foundation of America, a Senior Editor of the Journal of Alzheimer's Disease, and the 14th President of the Society for Brain Mapping & Therapeutics.
Dr. Ashford obtained a BA the University of California, Berkeley in 1970. At UCLA (1970–1985) he attained an MD (1974) and PhD (1984), trained in psychiatry (1975-1979), co-founded the Neurobehavior Clinic, and was the first Chief Resident and Associate Director (1979-1980) on the Geriatric Psychiatry In-Patient Unit. He conducted the first double-blind study of an anti-cholinesterase drug (physostigmine) to treat Alzheimer patients (Ashford et al., 1981), a therapy which is now standard treatment for Alzheimer patients. Between 1980-1985, Dr. Ashford directed the Geriatric Psychiatry Out-patient Clinic at the Neuropsychiatric Institute and initiated the UCLA/Alzheimer PET scan study with Dr. David Kuhl.
Between 1979-1984 under Dr. Joaquin Fuster, Dr. Ashford completed his Ph.D. dissertation, a finalist for the Lindsley Prize for the best in Behavioral Neuroscience in 1984. With Dr. Fuster, he made the first proposal and physiologic demonstration of massive, reciprocal parallel information processing in the cerebral cortex (Ashford et al., 1985); a basis of memory, particularly that aspect of memory affected by Alzheimer’s disease (Ashford, Coburn, and Fuster, 1998). His Alzheimer and neurophysiology study led to the water-shed observation that neuroplastic memory mechanisms of the brain are specifically affected by Alzheimer pathology (Ashford & Jarvik, 1985; Ashford, 2015).
Dr. Ashford was an Assistant Professor of Psychiatry at the Southern Illinois University School of Medicine between 1985-1990, helping to establish an NIA-funded Alzheimer’s Disease Center. There he published the first use of Modern Test Theory in the field of Medicine, “Item-Response Theory” analysis of the Mini-Mental State Exam (Ashford et al., 1989). He was an Associate Professor of Psychiatry at the University of California, Davis 1991-1992, at the Martinez, VAMC, and Chief of the Mental Hygiene Clinic. He was at the University of Kentucky from 1992-2003 as a tenured Associate Professor in Psychiatry, Neurology, and the Sanders-Brown Center on Aging, and Vice-Chair for Research in the Department of Psychiatry, where he continued his Alzheimer research. He proposed a “Time-Index” method to measure Alzheimer dementia severity (Ashford et al., 1995; Ashford & Schmitt, 2001), used in the UK Nun Study (Butler, Ashford, Snowden, 1996), and to study loss of cerebral perfusion in Alzheimer patients (Ashford et al., 2000). With Dr. James Geddes he showed the central role of paired helical filament pathology in destroying neuronal processes (Ashford et al., 1998).
Dr. Ashford’s long-term research interests are aging, Alzheimer’s disease, brain imaging, and memory mechanisms. He has developed early detection and measurement methods for mild cognitive disorders and Alzheimer’s disease, currently working on an internet program: www.memtrax.com . He is reformulating theories of Alzheimer pathology. As Director of WRIISC CA, he has studied traumatic brain injury, post-traumatic stress disorder, chronic pain, chronic multi-symptom illness, and other neuropsychiatric illnesses.
Complete List of Published Work in MyBibliography: (140 references)
https://www.ncbi.nlm.nih.gov/sites/myncbi/john.ashford.1/bibliography/48071896/public/?sort=date&direction=descending -
Sherry Ann Beaudreau
Clinical Professor (Affiliated), Psych/General Psychiatry and Psychology (Adult)
Staff, Psychiatry and Behavioral SciencesBioDr. Beaudreau is a licensed clinical psychologist with board certification in geropsychology. As PI of the Mental Health, Neurocognition, and Treatment in Older Adults lab, she conducts late life clinical research and mentors trainees in the Sierra Pacific Mental Illness Research Education and Clinical Center at VA Palo Alto. Nationally, she directs the 28-site VA Advanced Fellowship Program in Mental Illness Research and Treatment. She holds appointments as Clinical Professor (Affiliated) in the Department of Psychiatry and Behavioral Sciences at Stanford University School of Medicine and as an Honorary Associate Professor in the School of Psychology at the University of Queensland in Brisbane, Australia. In her capacity as a VA Subject Matter Expert in Problem Solving Training, she is actively involved in clinician trainings, consultation, and development of program materials for the national roll-out of Problem Solving Therapy for Suicide Prevention.
Her overarching research aims to leverage knowledge about the cognitive profiles of older adults with psychiatric disorders or at risk for suicide to inform the development and optimization of psychiatric behavioral interventions, including Problem Solving Therapy. She is the PI of a 5-year, multi-site randomized control trial to determine the efficacy of Problem Solving Therapy for reducing suicidal ideation over and above usual care. She is a Fellow of the Behavioral and Social Sciences section for Gerontological Society of America and the division of Adult Aging and Development for American Psychological Association. Additionally, she serves on several journal editorial boards including American Psychologist, Clinical Psychology: Science and Practice, and Clinical Gerontologist. In the department, she co-chairs the Stanford/VA Palo Alto interdepartmental Geriatric Psychiatry and Neuroscience Grand Rounds, an interdisciplinary forum featuring national and international experts in geriatrics (http://med.stanford.edu/psychiatry/education/gpngrandrounds.html) and is a member of the departmental Nominations and Awards committee. -
Geno Carvalho
YogaX Program Manager, Psychiatry and Behavioral Sciences
BioGeno Carvalho (He/Him)
MPH, E-RYT500, NBC-HWC, CPT, FNTP
YogaX Program Manager
Geno is a passionate health educator dedicated to helping people make healthy choices and increasing access to health services. As a health educator, teacher, trainer, and coach Geno integrates yoga services with exercise and nutrition programs in clinical settings to promote wellness, prevent disease, rehabilitate injuries, and manage pain. His work is grounded in yoga teachings, the pillars of lifestyle medicine, and the essential services of public health.
Geno has a Master's of Public Health and Recreation with an emphasis on Community Health Education. He is a 500HR Experienced-Registered Yoga Teacher, National Board Certified Health and Wellness Coach, Certified Personal Trainer, and Functional Nutritional Therapy Practioner.
Geno works to promote complete physical, mental, and social well-being and address health equity through coalition building and policy innovation. His work aims to increase individual and collective access to integrative care and build community capacity to empower people to proactively embrace a healthy life informed by their communities' collective experiences. -
Steven Chan, MD MBA
Clinical Associate Professor (Affiliated), Psych/Public Mental Health & Population Sciences
Staff, Psychiatry and Behavioral SciencesBioDr. Steven Chan is a Faculty Co-Director at Stanford Frontier Technology Lab, a member of Stanford Psychiatry’s TechHub Leadership Committee, faculty with the Stanford Addiction Medicine Fellowship, and a clinical educator caring for patients with substance use disorders (SUD) and addictions.
Dr. Chan is a clinical informaticist, addiction medicine physician, and psychiatrist. He is a clinical associate professor affiliated with the Stanford University School of Medicine, and Immediate Past Chair of the Committee on Innovation at the American Psychiatric Association. Dr. Chan is a sought-after national speaker whose ideas, thoughts, and research have been featured at Google headquarters, JAMA, Telemedicine and e-Health, JMIR (Journal of Medical Internet Research), Wired, PBS, and NPR Ideastream. He serves as Chief Technology Officer and co-founder of AsyncHealth — a University of California-backed digital mental health startup supported by Berkeley SkyDeck PAD-13 and the National Science Foundation's Innovation Corps (NSF i-Corps) — and writes at both @stevenchanMD and @mpowerhacks. -
William O Faustman
Clinical Professor (Affiliated), Psych/Public Mental Health & Population Sciences
Staff, Psychiatry and Behavioral SciencesBioDr. Faustman received his doctorate in clinical psychology from the University of Mississippi and completed his internship at the VA Palo Alto Health Care System. He has an active interest in training/coaching and clinical care in inpatient psychiatry. His research interests have focused on severe mental illness with an emphasis in areas such as cognition, psychopharmacology, and clinical assessment.. He serves as a member of the Stanford IRB. He has previously served as the coordinator of the American Psychological Association accredited postdoctoral fellowship program at the VA Palo Alto. He holds Chartered Psychologist status with the British Psychological Society,
-
George Mark Freeman MD PhD
Clinical Associate Professor (Affiliated), Psych/General Psychiatry and Psychology (Adult)
Staff, Psychiatry and Behavioral SciencesBioDr. Freeman serves as the Site Director for Stanford Psychiatry Residency Training at VA Palo Alto Hospital. His interests include caring for patients with complex mental health conditions, providing medical education to Stanford trainees, and remaining up to date on the latest in neuroscience advances.
EDUCATION
B.S. Biology (Neuroscience), Duke University
M.D. Medical Scientist Training Program, Washington University in St Louis
Ph.D. In Biological and Biomedical Sciences (Neuroscience), Washington University in St Louis
RESIDENCY TRAINING
Psychiatry Residency (Research Track), Stanford University School of Medicine, Stanford, CA
LICENSURE AND CERTIFICATION
Diplomate, General Psychiatry, American Board of Psychiatry and Neurology
Physician and Surgeon Medical License, California
SELECTED SCHOLARSHIPS AND HONORS
National Institute of Mental Health (NIMH) Outstanding Resident Award
James L. O’Leary Prize for Research in Neuroscience Finalist
Ruth L Kirschstein National Research Service Award
United States Fulbright Scholar -
Ansgar Furst
Clinical Associate Professor (Affiliated), Psych/Public Mental Health & Population Sciences
Staff, Psychiatry and Behavioral SciencesBioDr. Furst is a Clinical Associate Professor (affiliated) of Psychiatry and Behavioral Sciences and of Neurology and Neurological Sciences at Stanford University School of Medicine. He is a Principal Investigator and Director of the California War Related Illness and Injury Study Center (WRIISC) Advanced Fellowship Post-Doctoral program and Associate Director of Neuroimaging. He is also a Senior Research Scientist at the Polytrauma System of Care (PSC) at VA Palo Alto Health Care System. Dr. Furst serves as Associate Editor for the journal Frontiers in Neurology and is a member of the editorial board of NEUROLOGY. His research focuses on chronic multisymptom illness, traumatic brain injury, sleep, pain and neurodegenerative diseases.
For more information please visit:
https://med.stanford.edu/furstlab.html
Member of:
Center for Sleep and Circadian Sciences
https://med.stanford.edu/cscs.html
Faculty Affiliate:
Wu Tsai Human Performance Alliance
https://humanperformance.stanford.edu -
Joseph Garner
Professor of Comparative Medicine and, by courtesy, of Psychiatry and Behavioral Sciences
Current Research and Scholarly InterestsThe medical research community has long recognized that "good well-being is good science". The lab uses an integrated interdisciplinary approach to explore this interface, while providing tangible deliverables for the well-being of human patients and research animals.
-
Ola Golovinsky
Medical Education Team Manager, Psychiatry and Behavioral Sciences
Current Role at StanfordMedical Education Team Manager, Department of Psychiatry & Behavioral Science
-
Michael Greicius, MD, MPH
Iqbal Farrukh and Asad Jamal Professor and Professor, by courtesy, of Psychiatry and Behavioral Sciences (Administrative and Academic Special Programs)
Current Research and Scholarly InterestsAs the Founding Director of the Stanford Center for Memory Disorders and Principal Investigator of a lab focused on the genetics of Alzheimer's disease (AD), Dr. Greicius' research focuses on elucidating the neurobiologic underpinnings of AD. His lab combines cutting edge brain imaging, "deep" phenotyping, and whole-genome sequencing of human subjects to identify novel pathways involved in AD pathogenesis. The goal of his work is to develop effective treatment for AD patients.
-
Heather Kenna Hall
Director of Faculty Affairs & Strategic Planning, Psychiatry and Behavioral Sciences
BioHeather has been part of the Department of Psychiatry and Behavioral Sciences at Stanford since 2002. She directly manages appointment matters related to Professoriate faculty and supervises a team of faculty affairs administrators who manage appointment matters for faculty on the Clinician Educator line and other faculty appointment lines in the Department. Further responsibilities include supervision of medical education team members and contributions to strategic planning and development of new departmental initiatives. Prior to her current work in faculty affairs, Heather was as a clinical research manager in the Stanford Depression Research Center and the Stanford Women’s Wellness Clinic. She has published 40+ research articles in psychiatry and neuroscience journals. Her education includes a Master of Science in Psychology, as well as a Master of Arts in Social Psychology.
-
Mindy Hantke
Public Rel Offcr 3, Psychiatry and Behavioral Sciences
Current Role at StanfordWeb & Communications Administration
-
Erin Heinemeyer, PsyD
Affiliate, Psychiatry and Behavioral Sciences
BioDr. Erin Heinemeyer is an Associate Professor at Palo Alto University and a faculty member in the PAU–Stanford PsyD Consortium. Her clinical interests include complex trauma and PTSD, functional neurological disorder, and personality, depressive, and anxiety disorders. As part of her role in the Consortium, she serves as Practicum Co-Director at the VA Palo Alto Outpatient Mental Health Clinic and provides clinical supervision to doctoral and postdoctoral trainees. She also teaches Biological Bases of Behavior, advises doctoral students, and serves on dissertation committees. In addition, she maintains a psychotherapy practice in the community through a private group practice. Dr. Heinemeyer earned her PsyD from the PGSP–Stanford Consortium, completed her internship at the VA Loma Linda Healthcare System, and her postdoctoral fellowship at Stanford University School of Medicine, Department of Psychiatry and Behavioral Health Sciences.
-
Lisa Robin Jacobs, MD, MBA
Adjunct Clinical Assistant Professor, Psychiatry and Behavioral Sciences
BioDr. Jacobs is a child, adolescent & adult psychiatrist in private practice in Menlo Park, CA and an Adjunct Clinical Assistant Professor in the Department of Psychiatry & Behavioral Sciences of the Stanford University School of Medicine. She serves as the Assistant Director of The Pegasus Physician Writers at Stanford and is the Editor at Large of The Pegasus Review. She eared a BA from Cornell University, an MBA from the University of Rochester, and completed medical school at Brown University.
-
Max Kasun
Research Professional, Psychiatry and Behavioral Sciences
BioMax Kasun works in the Roberts Ethics Lab and Kim Ethics Lab at Stanford, which use empirical methods to help anticipate, clarify, and resolve ethical issues in modern biomedical research and clinical care. He received his BA from the University of Wisconsin-Madison. He has interests in empirical and normative thought dedicated to increasing scientific understanding and societal appreciation of the nature, experience, and prevalence of mental illness and wellbeing. More broadly, he is interested in moral philosophy (e.g. justice, action, capability, neo-Aristotelianism, and pragmatism), cognitive and affective sciences, and philosophy of mind (e.g. embodiment and personhood). He has co-authored scientific, peer-reviewed articles and other scholarly work investigating ethical issues in research that involves human volunteers (e.g. authentic voluntarism in informed consent (National Institutes of Health; PI: Dr. Laura Weiss Roberts)), psychiatric ethics, medical education, public health, and neuroscience. His most recent contributions to NIH-funded scientific work (National Center for Advancing Translational Sciences; PI: Dr. Jane Kim) have focused on investigating ethical issues encountered in the design, development, and clinical integration of artificial intelligence, e.g., how environmental and cognitive factors shape appraisals of AI tools, clinical judgments, trust, and health decision-making.
Max is a co-author of several chapters in APA's Study Guide to DSM-5-TR (2024) including the chapters on bipolar and related disorders and personality disorders (American Psychiatric Association). He has published work in and provided editorial support for the peer-reviewed journal Academic Medicine (Oxford University Press) and for two works on the subject of trauma and crisis and related interventions, including a reference guide for providing mental health care to victims of state atrocity (United Nations, Springer). Previously, he served on leadership teams for the Stanford Mental Health Technology and Innovation Hub and Neurodiversity Project.
Max is currently working on developing a new Special Initiative of the Chair on Mental Health Care for Unhoused and Justice-Involved Persons (see https://med.stanford.edu/psychiatry/special-initiatives/mhuj.html). The initiative aims to bring together a community of scholars, public stakeholders, and health care professionals to advance more humane and participatory inquiry and health policy in service of a population that faces profound controversy, health stigma, and scientific neglect. The initiative aims to improve how science is communicated to the public and policy decision-makers and to develop more evidence-based, pragmatic, strengths-based, and trauma-informed approaches to mental health care for unhoused persons, including those who have experienced episodic or cyclical involvement in the criminal and civil justice systems. -
Edwin Kim
Clinical Assistant Professor (Affiliated), Psych/General Psychiatry and Psychology (Adult)
Staff, Psychiatry and Behavioral SciencesBioDr. Edwin Kim, MD FAPA is an expert and leader in addiction treatment and physician health, who is board-certified in Psychiatry, Addiction Medicine, and Addiction Psychiatry. Dr. Kim is the Director of Addiction Treatment Services at the Veterans Affairs Palo Alto Healthcare System, and a Clinical Assistant Professor (Affiliated) at Stanford University School of Medicine. At the VA Palo Alto, Dr. Kim teaches and supervises medical students, residents and fellows. He is also the President-Elect of the Federation of State Physician Health Programs, and a Councilor-at-Large of the Northern California Psychiatric Society. He currently serves as a Medical Director at the Foundation of the Pennsylvania Medical Society’s Physicians’ Health Program and Nurses’ Health Program.
-
Helena Chmura Kraemer
Professor of Biostatistics in Psychiatry, Emerita
Current Research and Scholarly InterestsI am interested in the methodology pertinent to dealing with research problems where biological and behavioral interests meet. These interests have been applied not only in psychiatric research, but in those areas of Cardiology, Pediatrics and other fields of medicine in which behavioral research is becoming ever more salient.
-
Douglas F. Levinson, M.D.
Walter E. Nichols, M.D. Professor in the School of Medicine, Emeritus
Current Research and Scholarly InterestsDr. Levinson directs the Program on the Genetics of Brain Function in the Department of Psychiatry and Behavioral Sciences. The program investigates the genetic basis of psychiatric disorders (schizophrenia and major depressive disorder), using genetic association, linkage and resequencing methodologies. In collaboration with Dr. Alice Whittemore, we are also actively engaged in statistical methods testing and development for genetic research.
-
Eric Lin
Clinical Assistant Professor (Affiliated), Psych/General Psychiatry and Psychology (Adult)
Staff, Psychiatry and Behavioral SciencesBioEric Lin, MD, is a Clinical Assistant Professor (Affiliated) of Psychiatry and Behavioral Sciences at Stanford University School of Medicine and an addiction psychiatrist at VA Palo Alto. His academic work focuses on artificial intelligence, large language models, machine learning, and psychiatry, with particular interest in the clinical evaluation, safety, and governance of AI systems used in mental health care and related psychological contexts.
Dr. Lin studies how AI systems should be assessed when they interact with patients, clinicians, or psychologically vulnerable users. His work addresses the limitations of benchmark-driven evaluation and the need for clinically meaningful approaches to AI evaluation that incorporate psychiatric expertise, real-world clinical complexity, and post-deployment risk. His broader interests include psychopathology, personality assessment, psychoanalytic and psychodynamic models of mind, and the translation of complex clinical judgment into rigorous evaluation frameworks for emerging technologies.
Dr. Lin completed psychiatry residency at Yale University, where he trained in the Neuroscience Research Training Program, and later completed a medical informatics fellowship through VA Boston, with research at Harvard Medical School/McLean Hospital on computational and digital approaches to psychiatric phenotyping. He is board certified in psychiatry and clinical informatics. His clinical and teaching work in addiction psychiatry grounds his interest in psychiatric complexity, risk assessment, care navigation, and pragmatic implementation of AI tools in health care. He is interested in collaborations across psychiatry, computer science, human-centered AI, health policy, digital mental health, and responsible technology development. -
M Windy McNerney, PhD
Clinical Associate Professor (Affiliated), Psych/General Psychiatry and Psychology (Adult)
Staff, Psychiatry and Behavioral SciencesBioDr. M. Windy McNerney is the Director of Biological Sciences for the MIRECC at the Department of Veterans Affairs in Palo Alto, and a Clinical Associate Professor (Affiliated) at Psychiatry and Behavioral Sciences at Stanford School of Medicine. Dr. McNerney holds a particular passion for not only understanding the neurophysiology and biochemistry of mental health diseases, but also advocating for these invisible diseases. Her research focuses on neurodegeneration, depression, TBI, PTSD, and addiction. She is collaborating with researchers to integrate brain imaging and biochemical markers in hopes to better understand these diseases. She also is taking a lead role at the VA in investigating the biochemistry of magnetic brain stimulation and is the leader of the NeuroNado Laboratory. At Stanford University, she is the professor of two popular courses examining the biological and societal issues surrounding substance use disorder, with a major focus on opioids such as fentanyl. She has individually mentored over 25 students from underrepresented groups in STEM activities and leads monthly seminars aimed at facilitating career development. In her free time, she is a community advocate for the treatment of mental health and educates groups about the dangers of fentanyl.
She earned her BS from UC Davis and her PhD from the University of Notre Dame. While at ND, she interned at NASA Ames on Human Factors Engineering. She then went on to a postdoctoral position at Lawrence Livermore National Laboratory (DOE), and then completed a fellowship at the WRIISC program at the VA and Stanford University.
Selected Publications:
McNerney MW, Gurkoff G, Berryhill M (2023). The rehabilitation potential of neurostimulation for mild traumatic brain injury in animal and human studies. Brain Sciences, 13, 1402.
McNerney MW, Kraybill EP Narayanan S, Mojabi F, Venkataramanan V, Heath A (2023). Memory-related hippocampal brain-derived neurotrophic factor activation pathways from repetitive transcranial magnetic stimulation in the 3xTg-AD mouse line. Experimental Gerontology, 183, 11323.
Shuken, S, McNerney MW (2023). Cost and benefits for popular p-value correction methods I three models of quantitative omic experiments. Analytical Chemistry, 95, 2732.
McNerney MW, Heath A, Narayanan S, Yesavage J (2022). Repetitive transcranial magnetic stimulation improves brain-derived neurotrophic factor and cholinergic signaling in the 3xTgAD mouse model of Alzheimer’s disease. Journal of Alzheimer’s Disease, 86, 499..
Heath AM, Brewer M, Yesavage J, McNerney MW. (2021). Improved object recognition memory using post-encoding repetitive transcranial magnetic stimulation. Brain Stimulation, 15, 78.
Yang AC, Vest RT, Kern F, Lee DP, Agam M, Maat CA, Losada PM, Chen MB, Schaum N, Khoury N, Toland A, Calcuttawala K, Shin H, Palovics R, Shin A, Wang EY, Luo J, Gate D, Schultz-Schaeffer WJ, Chu P, Siegenthalar J, McNerney MW, Keller A, Wyss-Coray T (2022). A human brain vascular atlas reveals diverse mediators or Alzheimer’s disease. Nature, 603, 885.
McNerney MW, Hobday T, Cole B, Ganong R, Winas N, Matthews D, Hood J, Lane S (2019). Objective classification of mTBI using machine learning on a combination of frontal electroencephalography measurements and self-reported symptoms. Sports Medicine Open, 4, 14.
McNerney MW, Sheng T, Nechvatal JM, Lee A, Lyons D, Adamson M (2018). Integration of neural and epigenetic contributions to posttraumatic stress symptoms: The role of hippocampal volume and glucocorticoid receptor gene methylation. PLOSONE, e0192222.
Bennion BJ, Be NA, McNerney MW, Lao V, Carlson E, Valdez CA (2017). Predicting a drug’s membrane permeability: A computational model validated with in vitro permeability assay data. Journal of Physical Chemistry, B, 121, 5228.
See more publications at: https://www.ncbi.nlm.nih.gov/pubmed/?term=McNerney%20MW%5BAuthor%5D&cauthor=true&cauthor_uid=17107728 -
Zariah Mekile
Affiliate, Psychiatry and Behavioral Sciences
BioZariah J. Mekile, MS, MAP, is a doctoral candidate at the PGSP-Stanford Psy.D. Consortium, where she is pursing her PsyD in Clinical Psychology. She completed a BA in psychology with a minor in cognitive science and Spanish at Elizabethtown College, and a Master of Applied Psychology at Rutgers University-Graduate School of Applied and Professional Psychology.
-
Colleen Mills-Finnerty
Clinical Assistant Professor (Affiliated), Psych/Public Mental Health & Population Sciences
Staff, Psychiatry and Behavioral SciencesBioDr. Mills-Finnerty received her PhD in Psychology from Rutgers University, with a focus on cognitive neuroscience. She completed a MIRECC Advanced Fellowship at the Palo Alto VA and Stanford Dept. Psychiatry and Behavioral Sciences, studying mood disorders using neuroimaging and neurostimulation. She was then awarded a VA Career Development Award to study attention and reward function in mood disorders. She joined the Women’s Operational Military Exposures Network as a Research Scientist in 2024. She is interested in health disparities that impact neurological and mental health in women Veterans, and their relationship to Military Environmental Exposures.
She has authored multiple award-winning papers, including “Affective Neuroscience: Applications for Sexual Medicine Research and Clinical Practice,” proposing a novel treatment schema for sexual trauma based on affective neuroscience, which was awarded the Bronze Prize for Best Paper by the International Society for Sexual Medicine. -
Clayton Olash
Affiliate, Psychiatry and Behavioral Sciences
BioClayton Olash, MD is a psychiatry resident at the Medical University of South Carolina and an affiliate researcher with Stanford University. His work bridges psychiatry, neuroscience, and contemplative traditions, with a focus on how altered states of consciousness can catalyze lasting psychological change.
Clayton's current research spans multiple projects, including studies on ibogaine and its impact on the default mode network, rapid-acting neuromodulation techniques such as SAINT TMS combined with meditation, and a novel high-dose electrotherapy device for home-based treatment of depression. His broader aim is to understand how psychedelics, brain stimulation, and meditative practices can modulate self-related processing and promote enduring well-being.
With backgrounds in philosophy, psychology, and medicine, Clayton's work emphasizes integration: uniting ancient contemplative wisdom with modern neuroscience and emerging technologies. His long-term goal is to develop translational models of care that transform transient altered states into sustainable therapeutic traits. -
Adolf Pfefferbaum
Professor of Psychiatry and Behavioral Sciences, Emeritus
Current Research and Scholarly InterestsDevelopment and application of magnetic resonance imaging approaches for in vivo studies of human and animal brain integrity in neurodegenerative conditions, including alcoholism, HIV infection, Alzheimer's disease, and normal aging
-
Russell Poldrack
Albert Ray Lang Professor of Psychology and, by courtesy, of Psychiatry and Behavioral Science
Current Research and Scholarly InterestsOur lab uses the tools of cognitive neuroscience to understand how decision making, executive control, and learning and memory are implemented in the human brain. We also develop neuroinformatics tools and resources to help researchers make better sense of data.
-
Reiko Riley
Director of Education and Program Development, Psychiatry and Behavioral Sciences
Current Role at StanfordSr. Education Program Manager
Member of the Diversity, Equity, and Inclusion Advisory Committee (Psychiatry and Behavioral Sciences) -
Laura Roberts, MD, MA
Katharine Dexter McCormick and Stanley McCormick Memorial Professor
Current Research and Scholarly InterestsDr. Roberts has performed numerous empirical studies of contemporary ethics issues in medicine and health policy and has been funded by the National Institutes of Health, the Department of Energy, the National Alliance of Schizophrenia and Depression, the Arnold P. Gold Foundation, and other private and public foundations.
-
Allyson Rosen, Ph.D., ABPP-CN
Clinical Professor (Affiliated), Psych/Public Mental Health & Population Sciences
Staff, Psychiatry and Behavioral SciencesBioRESEARCH FOCUS
Translational cognitive neuroscience of aging and dementia. Neuroethics.
TRAINING
Dr. Rosen is board certified in clinical neuropsychology with a geriatric focus. She completed college at Brown University, a clinical psychology Ph.D. from Case Western Reserve University, clinical neuropsychology internship at the Long Island Jewish Hospital in New York, and clinical neuropsychology postdoctoral fellowship at the Medical College of Wisconsin. Dr. Rosen completed specialty research fellowship training at the National Institute on Aging (Intramural Research Training Award) and Stanford (NRSA F32, K01) in functional imaging and noninvasive brain stimulation with support from NIA.
CLINICAL AND RESEARCH ACTIVITIES
Dr. Rosen is Director of Dementia Education at the Mental Illness Research Education and Clinical Center at the Palo Alto VAHCS. She is also a neuropsychologist and part of the consensus clinical group and education core at the Stanford’s Alzheimer’s Disease Research Center (NIA). Dr. Rosen’s funded research has focused on applying cognitive neuroscience of aging to improve clinical practice in older adults by using cognitive measures, brain imaging, and noninvasive brain stimulation such as TMS. Studies include using fMRI as an outcome measure for cognitive training, studying how to improve the accuracy of transcranial magnetic stimulation targeting with and without image guidance, and using structural MRI to avoid postoperative cognitive decline and improve outcome from carotid vascular procedures. She has a longstanding commitment to neuroethics and leads a feature in the Journal of Alzheimer Disease that focuses on ethical issues in new and emerging AD applications.
ETHICS EDITOR, JOURNAL OF ALZHEIMER'S DISEASE
Ethics Review
http://www.j-alz.com/blogs/discussion/protecting-progress
MIRECC DEMENTIA EDUCATION
http://www.mirecc.va.gov/visn21/education/dementia_education.asp
